Ayala Pharmaceuticals Inc (AYLA)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2021-02-26 | 2021-02-24 | PS Planned sale |
Chief Medical Officer Officer |
3,000
-26.0%
17.46USD 52,385 |
3,000 -26.0% | 17.46 | USD 52,385 | |
| 2021-02-24 | 2021-02-24 | PS Planned sale |
President & CEO Executive Director |
10,800
-6.9%
17.40USD 187,919 |
10,800 -6.9% | 17.40 | USD 187,919 | |
| 2021-02-24 | 2021-02-23 | PS Planned sale |
President & CEO Executive Director |
7,126
-4.4%
17.89USD 127,483 |
7,126 -4.4% | 17.89 | USD 127,483 | |
| 2021-02-24 | 2021-02-22 | PS Planned sale |
President & CEO Executive Director |
15,200
-8.5%
19.86USD 301,813 |
15,200 -8.5% | 19.86 | USD 301,813 | |
| 2021-01-22 | 2021-01-21 | PS Planned sale |
President & CEO Executive Director |
1,406
-0.8%
15.04USD 21,147 |
1,406 -0.8% | 15.04 | USD 21,147 | |
| 2021-01-22 | 2021-01-20 | PS Planned sale |
Chief Medical Officer Officer |
3,000
-26.0%
15.03USD 45,084 |
3,000 -26.0% | 15.03 | USD 45,084 | |
| 2021-01-22 | 2021-01-20 | PS Planned sale |
President & CEO Executive Director |
19,466
-9.8%
15.03USD 292,533 |
19,466 -9.8% | 15.03 | USD 292,533 | |
| 2021-03-08 | 2020-12-23 | B Purchase | Non-Executive Director |
4
+1.6%
11.56USD 46 |
4 +1.6% | 11.56 | USD 46 | |
| 2021-03-08 | 2020-09-14 | B Purchase | Non-Executive Director |
1
+0.4%
10.70USD 11 |
1 +0.4% | 10.70 | USD 11 | |
| 2021-03-08 | 2020-09-11 | B Purchase | Non-Executive Director |
10
+4.3%
10.07USD 101 |
10 +4.3% | 10.07 | USD 101 | |
| 2021-03-08 | 2020-08-14 | B Purchase | Non-Executive Director |
5
+2.2%
11.07USD 55 |
5 +2.2% | 11.07 | USD 55 | |
| 2021-03-08 | 2020-07-17 | B Purchase | Non-Executive Director |
4
+1.8%
11.86USD 47 |
4 +1.8% | 11.86 | USD 47 | |
| 2021-03-08 | 2020-07-07 | B Purchase | Non-Executive Director |
1
+0.4%
9.60USD 10 |
1 +0.4% | 9.60 | USD 10 | |
| 2021-03-08 | 2020-05-12 | B Purchase | Non-Executive Director |
25
+12.5%
15.02USD 376 |
25 +12.5% | 15.02 | USD 376 | |
| 2020-05-14 | 2020-05-12 | B Purchase | Large shareholder |
500,000
+30.1%
15.00USD 7,500,000 |
500,000 +30.1% | 15.00 | USD 7,500,000 | |
| 2020-05-14 | 2020-05-12 | B Purchase | Large shareholder |
50,000
+3.1%
15.00USD 750,000 |
50,000 +3.1% | 15.00 | USD 750,000 | |
| 2020-05-14 | 2020-05-12 | B Purchase | Large shareholder |
225,000
+7.3%
15.00USD 3,375,000 |
225,000 +7.3% | 15.00 | USD 3,375,000 | |
| 2020-05-14 | 2020-05-12 | B Purchase |
aMoon 2 Fund Limited Partnership Large shareholder |
800,000
+36.5%
15.00USD 12,000,000 |
800,000 +36.5% | 15.00 | USD 12,000,000 | |
| 2021-03-08 | 2020-05-08 | B Purchase | Non-Executive Director |
200
+inf%
15.27USD 3,054 |
200 +inf% | 15.27 | USD 3,054 |